Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02780700
Title Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Fort Wayne Medical Oncology Hematology Fort Wayne Indiana 46845 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field